Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IPGP
IPGP logo

IPGP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy IPG Photonics Corp (IPGP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
114.590
1 Day change
6.41%
52 Week Range
155.820
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IPG Photonics Corp (IPGP) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown strong financial growth in the latest quarter and has positive long-term prospects, the technical indicators and options data suggest a neutral to slightly bearish short-term outlook. Additionally, analysts' mixed ratings and the lack of recent positive news or catalysts do not support an immediate buy decision.

Technical Analysis

The MACD is negatively expanding, RSI is neutral at 46.059, and moving averages are converging, indicating no strong trend. The stock is trading near a pivot level of 119.908, with resistance at 128.052 and support at 111.764. The technical indicators suggest a neutral to slightly bearish outlook.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the implied volatility is high (68.24) with an IV percentile of 95.62, suggesting elevated risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • Strong Q4 financial performance with revenue up 17.13% YoY, net income up 69.80% YoY, and EPS up 72.22% YoY. Expansion into defense, medical, and systems markets supports a higher-margin, less-cyclical business mix.

Neutral/Negative Catalysts

  • Gross margin dropped by -6.36% YoY, signaling potential cost pressures. Analysts have mixed ratings, with one downgrade citing much of the near-term upside already priced in. No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

In 2025/Q4, revenue increased to $274.47M (up 17.13% YoY), net income increased to $13.27M (up 69.80% YoY), and EPS increased to $0.31 (up 72.22% YoY). However, gross margin dropped to 36.1% (down -6.36% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Stifel raised the price target to $165 and maintains a Buy rating. Raymond James downgraded to Outperform from Strong Buy but raised the price target to $180. Roth Capital raised the price target to $110 and maintains a Buy rating. Analysts are mixed, with some citing strong financial performance but cautioning that much of the upside is already priced in.

Wall Street analysts forecast IPGP stock price to fall
4 Analyst Rating
Wall Street analysts forecast IPGP stock price to fall
2 Buy
1 Hold
1 Sell
Hold
Current: 107.690
sliders
Low
77.5
Averages
95.83
High
110
Current: 107.690
sliders
Low
77.5
Averages
95.83
High
110
Stifel
Buy
upgrade
$92 -> $165
AI Analysis
2026-02-13
Reason
Stifel
Price Target
$92 -> $165
AI Analysis
2026-02-13
upgrade
Buy
Reason
Stifel raised the firm's price target on IPG Photonics to $165 from $92 and keeps a Buy rating on the shares.
Raymond James
Strong Buy -> Outperform
downgrade
$97 -> $180
2026-02-13
Reason
Raymond James
Price Target
$97 -> $180
2026-02-13
downgrade
Strong Buy -> Outperform
Reason
Raymond James downgraded IPG Photonics to Outperform from Strong Buy with a price target of $180, up from $97. The firm's estimates and the price target are being raised following a strong Q4 beat, but the rating is trimmed after a sharp multiple re-rating and more than 100% year-to-date share appreciation, the analyst tells investors in a research note. IPG delivered revenue and earnings well above expectations with book-to-bill above 1x, signaling accelerating core demand, while expansion into defense, medical, and systems markets supports a higher-margin, less-cyclical mix, though much of the near-term upside now appears priced in, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IPGP
Unlock Now

People Also Watch